Estimates Revisions Mesoblast Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:15 2026-04-21 am EDT			5-day change	1st Jan Change
2.300 ^AUD	0.00%		+13.86%	-15.44%

Apr. 15	Mesoblast Buys License to Chimeric Antigen Receptor Technology Platform; Shares Up Pre-Bell	MT
Apr. 15	Australian Shares Flat; Virgin Australia Says Fiscal Year 2026 Guidance Unchanged, Fiscal H2 EBIT Expected to Rise	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	MESOBLAST LIMITED
	LONZA GROUP AG
	BEONE MEDICINES AG
	REVOLUTION MEDICINES, INC.
	CELLTRION, INC.
	IQVIA HOLDINGS INC.
	ASCENDIS PHARMA A/S
	MEDPACE HOLDINGS, INC.
	EUROFINS SCIENTIFIC SE
	Average
	Weighted average by Cap.